Top Suppliers:I want be here


1628805-46-8

1628805-46-8 structure
1628805-46-8 structure

Name IDH-305
Synonyms (4R)-4-[(1S)-1-fluoroethyl]-3-(2-{[(1S)-1-[4-methyl-2'-(trifluoromethyl)-[3,4'-bipyridin]-6-yl]ethyl]amino}pyrimidin-4-yl)-1,3-oxazolidin-2-one
Description IDH-305 is an inhibitor of isocitrate dehydrogenase (IDH).
Related Catalog
Target

IDH[1]

In Vitro IDH-305 is an inhibitor of isocitrate dehydrogenase (IDH). Isocitrate dehydrogenase (IDH) is an essential enzyme for cellular respiration in the tricarboxylic acid (TCA) cycle. The IDH1 inhibitor IDH-305 has entered an ongoing phase 1 clinical trial (NCT02381886) for patients with IDH1-R132 mutant advanced hematologic or solid malignancies[1].
References

[1]. Fujii T,et al. Targeting isocitrate dehydrogenase (IDH) in cancer. Discov Med. 2016 May;21(117):373-80.

Molecular Formula C23H22F4N6O2
Molecular Weight 490.46
Storage condition 2-8℃